Article
Impact of Genomic Mutation and Timing of Y90 Radioembolization in Colorectal Liver Metastases.
Cardiovascular and interventional radiology - 1 Jul 2020
Dabrowiecki Alexander, Sankhla Tina, Shinn Kaitlin, Bercu Zachary L, Ermentrout Mitchell, Shaib Walid, Cardona Kenneth, Newsome Janice, Kokabi Nima
Abstract excerpt
PURPOSE: To investigate timing of Yttrium-90 radioembolization (Y90) during treatment course, genomics, and other clinical factors as predictors of overall survival (OS) in colorectal liver metastasis (CRLM) that have progressed on at least one line of chemotherapy. MATERIALS AND METHODS: This was a retrospective study from 2013 to 2018 of patients with CRLM and genomic analysis prior to Y90 at a multihospital...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
